Subtle Medical, a firm headquartered in Menlo Park, California, won both FDA clearance and the European CE Mark of approval to introduce its SubltePET system on both sides of the Atlantic.
The system uses artificial intelligence techniques to improve the quality of fast positron-emission tomography (PET) scans, allowing patients to go through exams faster than before without suffering from poorer image resolution.
The technology not only improves the patient’s experience during scans, but clinics can image more patients and get a lot more usability out of a given PET scanner. “Focusing Subtle Medical’s SubtlePET AI platform on faster image acquisition, we have been able to dramatically increase PET scan efficiency and provide a superior patient experience. SubtlePET technology allows us to scan a patient four times faster than normal, yet maintain equal image quality, not otherwise impacting work flow,” in a published statements said Michael Brant-Zawadzki, MD, FACR, Hoag Hospital, Newport Beach, California. “This creates immediate ROI benefit for our hospital and a compelling value proposition. I’m looking forward to seeing more groundbreaking technology from the Subtle team.”
The SubtlePET system can work with just about any PET scanner, and it uses deep learning algorithms to automatically enhance images as they are produced by the scanner. The imaging workflow stays the same for the scanner operator, and the only real difference is improved images during rapid scans.
While the current product is only applicable for PET imaging, Sublte Medical is also developing a similar tool to speed up MRI scans, as well as one that reduces the amount of gadolinium used during contrast enhanced MRI scans.
Link: Subtle Medical homepage…